Utah Medical Products Inc (UTMD) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Utah Medical Products reported revenue of $38.5M, down 5.8% from $40.9M the year before. Net income was $11.3M (a 29.3% net margin), or $3.48 per diluted share. Gross margin was 57.1% and operating margin was 29.6%. Operating activities generated $14.7M of cash, leaving $14.3M of free cash flow. At fiscal year end, Utah Medical Products held $122.5M in total assets against $3.3M in total liabilities, including $85.8M of cash and equivalents.
Open the full interactive Utah Medical Products financials → Quarterly statements, key ratios, valuation history and price charts.
Utah Medical Products Key Stats
| Share Price | $74.71 |
|---|---|
| Market Cap | $237.9M |
| P/E Ratio | 21.5 |
| Dividend Yield | 1.66% |
| Revenue YoY Growth | -5.8% |
| 52-Week Range | $52.78 – $76.66 |
| Shares Outstanding | 3.2 million (basic, 2026 Q2) |
Utah Medical Products Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $42.2M | $49.1M | $52.3M | $50.2M | $40.9M | $38.5M |
| Cost of Goods Sold | $16.6M | $18.1M | $20.1M | $20.2M | $16.8M | $16.5M |
| Gross Profit | $25.5M | $30.9M | $32.2M | $30.0M | $24.1M | $22.0M |
| Operating Income | $13.7M | $18.9M | $19.8M | $16.8M | $13.6M | $11.4M |
| Pre-Tax Income | $13.8M | $19.1M | $20.7M | $20.1M | $16.8M | $14.1M |
| Income Tax | $3.0M | $4.3M | $4.2M | $3.5M | $2.9M | $2.8M |
| Net Income | $10.8M | $14.8M | $16.5M | $16.6M | $13.9M | $11.3M |
| Diluted EPS | $2.94 | $4.04 | $4.52 | $4.57 | $3.96 | $3.48 |
Utah Medical Products Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $9.8M | $9.0M | $8.7M | $8.5M |
| Net Income | $2.6M | $2.6M | $2.6M | $2.7M |
| Diluted EPS | $0.82 | $0.79 | $0.82 | $0.84 |
Utah Medical Products Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $51.6M | $61.0M | $75.1M | $92.9M | $83.0M | $85.8M |
| Current Assets | $62.3M | $73.2M | $89.9M | $106.3M | $96.3M | $97.7M |
| Total Assets | $111.7M | $115.6M | $123.9M | $135.5M | $122.5M | $122.5M |
| Current Liabilities | $3.8M | $3.7M | $6.0M | $4.7M | $3.8M | $2.6M |
| Total Long-Term Debt | — | — | — | — | $282,000 | $225,000 |
| Total Liabilities | $8.9M | $8.5M | $9.6M | $7.1M | $5.1M | $3.3M |
| Shareholders' Equity | $102.8M | $107.1M | $114.3M | $128.3M | $117.4M | $119.3M |
Utah Medical Products Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $20.1M | $21.2M | $21.1M | $22.3M | $14.8M | $14.7M |
| Cash From Investing | -$860,000 | -$552,000 | -$818,000 | -$639,000 | -$208,000 | -$371,000 |
| Cash From Financing | -$10.7M | -$10.9M | -$5.5M | -$4.2M | -$23.8M | -$12.3M |
| Free Cash Flow | $19.3M | $20.7M | $20.3M | $21.6M | $14.6M | $14.3M |
| Dividends Paid | $4.1M | $11.5M | $3.2M | $4.3M | $4.3M | $4.0M |
Figures from Utah Medical Products' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Utah Medical Products financials page for every line item.
Utah Medical Products Company Profile
| Ticker | UTMD |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Midvale, Utah |
| Incorporated in | Utah |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0000706698 |
Frequently Asked Questions
What was Utah Medical Products' revenue in fiscal 2025?
Utah Medical Products (UTMD) reported revenue of $38.5M for fiscal 2025.
What is Utah Medical Products' annual revenue history?
Utah Medical Products' annual revenue by fiscal year: 2020: $42.2M; 2021: $49.1M; 2022: $52.3M; 2023: $50.2M; 2024: $40.9M; 2025: $38.5M.
What was Utah Medical Products' net income in fiscal 2025?
Utah Medical Products reported net income of $11.3M for fiscal 2025.
What was Utah Medical Products' earnings per share (EPS) in fiscal 2025?
Utah Medical Products' diluted EPS was $3.48 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Utah Medical Products generate in fiscal 2025?
Utah Medical Products generated $14.3M of free cash flow in fiscal 2025.
What was Utah Medical Products' revenue last quarter?
In its most recent reported quarter (2026 Q2), Utah Medical Products reported revenue of $8.5M.
How much debt does Utah Medical Products have?
Utah Medical Products reported $225,000 of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Utah Medical Products are outstanding?
Utah Medical Products reported a weighted average of 3.2 million basic shares outstanding in 2026 Q2.
What is Utah Medical Products' market cap?
Based on its latest closing price, Utah Medical Products (UTMD) has a market capitalization of about $237.9M.
When does Utah Medical Products' fiscal year end?
Utah Medical Products' fiscal year end, as registered with the SEC, is December 31.
Where is Utah Medical Products headquartered?
Utah Medical Products lists its business address in Midvale, Utah in its SEC filings.
Utah Medical Products Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →